Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham P Taylor

Showing results (11-20 of 227) with videos related to

Pageof 23
Sort By:
Plos One|June 24, 2016
Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk TestAdine Adonis, Graham P Taylor
British Journal of Haematology|April 21, 2018
Can we reduce the incidence of adult T-cell leukaemia/lymphoma? Cost-effectiveness of human T-lymphotropic virus type 1 (HTLV-1) antenatal screening in the United KingdomBassit Malik, Graham P Taylor
Current Opinion in Infectious Diseases|December 6, 2013
Human T-lymphotropic virus/HIV co-infection: a clinical reviewDivya Dhasmana, Graham P Taylor
Current Opinion in Infectious Diseases|December 9, 2014
Syphilis testing, typing, and treatment follow-up: a new era for an old diseaseCraig Tipple, Graham P Taylor
Microorganisms|November 11, 2022
Current Interventions to Prevent HTLV-1 Mother-to-Child Transmission and Their Effectiveness: A Systematic Review and Meta-AnalysisCarolina Rosadas, Graham P Taylor
Sexually Transmitted Infections|October 16, 2025
Human T-cell lymphotropic virus type 1Daniel Bradshaw, Graham P Taylor
Oncogene|September 13, 2005
Natural history of adult T-cell leukemia/lymphoma and approaches to therapyGraham P Taylor, Masao Matsuoka
Frontiers in Medicine|February 21, 2022
HTLV-1 and Co-infectionsCarolina Rosadas, Graham P Taylor
Current Opinion in Infectious Diseases|September 19, 2015
Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?Lucy B Cook, Graham P Taylor
British Journal of Haematology|July 15, 2022
A new paradigm for the management of ATLGraham P Taylor, Lucy B Cook
Pageof 23

Showing results (11-20 of 227) with videos related to

Sort By:
Pageof 23
Plos One|June 24, 2016
Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk TestAdine Adonis, Graham P Taylor
British Journal of Haematology|April 21, 2018
Can we reduce the incidence of adult T-cell leukaemia/lymphoma? Cost-effectiveness of human T-lymphotropic virus type 1 (HTLV-1) antenatal screening in the United KingdomBassit Malik, Graham P Taylor
Current Opinion in Infectious Diseases|December 6, 2013
Human T-lymphotropic virus/HIV co-infection: a clinical reviewDivya Dhasmana, Graham P Taylor
Current Opinion in Infectious Diseases|December 9, 2014
Syphilis testing, typing, and treatment follow-up: a new era for an old diseaseCraig Tipple, Graham P Taylor
Microorganisms|November 11, 2022
Current Interventions to Prevent HTLV-1 Mother-to-Child Transmission and Their Effectiveness: A Systematic Review and Meta-AnalysisCarolina Rosadas, Graham P Taylor
Sexually Transmitted Infections|October 16, 2025
Human T-cell lymphotropic virus type 1Daniel Bradshaw, Graham P Taylor
Oncogene|September 13, 2005
Natural history of adult T-cell leukemia/lymphoma and approaches to therapyGraham P Taylor, Masao Matsuoka
Frontiers in Medicine|February 21, 2022
HTLV-1 and Co-infectionsCarolina Rosadas, Graham P Taylor
Current Opinion in Infectious Diseases|September 19, 2015
Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?Lucy B Cook, Graham P Taylor
British Journal of Haematology|July 15, 2022
A new paradigm for the management of ATLGraham P Taylor, Lucy B Cook
Pageof 23